Author:
Michel P,Adenis A,Fiore F Di,Boucher E,Galais M P,Dahan L,Mirabel X,Hamidou H,Raoul J L,Jacob J H,Hellot M F,Prod'Homme S,Paillot B
Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. Ajani JA, Baker J, Pisters PW, Ho L, Mansfield PF, Feig BW, Charnsangavej C (2002) CPT-11 plus cisplatin in patients with advanced, untreated gastric or gastroesophageal junction carcinoma: results of a phase II study. Cancer 94: 641–646
2. Bedenne L, Michel P, Bouche O, Triboulet JP, Conroy T, Pezet D, Roullet B, Seitz JF, Lacourt J, Milan C (2002) Randomized trial in locally advanced esophageal cancer: radiochemotherapy followed by surgery versus radiochemotherapy alone (FFCD9102). Proc Am Soc Clin Oncol 21, abstr 519
3. Bellisant E, Benichou J, Chastang C (1996) Application of the triangular test to phase II cancer clinical trials. Stat Med 9: 907–917
4. Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, Ove R, Kies MS, Baselga J, Youssoufian H, Amellal N, Rowinsky EK, Ang KK (2006) Radiotherapy plus cetuximab for squamous cell carcinoma of the head and neck. N Engl J Med 354: 567–578
5. Coia LR, Minsky BD, Berkey BA, John MJ, Haller D, Landry J, Pisansky TM, Willett CG, Hoffman JP, Owen JB, Hanks GE (2000) Outcome of patients receiving radiation for cancer of the esophagus: results of the 1992–1994 patterns of care study. J Clin Oncol 18: 455–462